The Column Group II, LP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:14 pm Sale |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 3,644,118 5.200% |
-27,404 (-0.75%) |
Filing |
| 2022-02-11 4:54 pm Sale |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 3,671,522 9.300% |
-1,096,659 (-23.00%) |
Filing |
| 2021-02-12 6:24 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 4,768,181 13.100% |
4,768,181 (New Position) |
Filing |